Jindal Supreme (India) IPO Final Day: GMP ₹27

Well, folks, it’s the final countdown for the Jindal Supreme (India) IPO on the NSE Mainboard. As the subscription window slams shut today, September 18th, 2026, we’re taking a deep dive into the Day 3 status. With the issue price fixed at ₹93 per share, the anticipation is palpable. Let’s see how the markets have responded on this crucial closing day.

Subscription Status

As of the latest updates, the subscription figures for Jindal Supreme are showing a rather subdued picture across all categories. We’re seeing 0x subscription in the Retail, NII (Non-Institutional Investor), and QIB (Qualified Institutional Buyer) segments, leading to a total subscription of 0x. Now, this is certainly something to ponder. Typically, on the closing day of an IPO, you’d expect to see some significant traction, especially from retail investors who often jump in towards the end. The current lack of substantial bids across the board could indicate a few things. It might suggest that investors are waiting for more concrete performance data or perhaps the issue isn’t resonating as strongly as anticipated. The absence of QIB and NII participation, in particular, is noteworthy. These are usually the more informed and often larger investors. Their silence could be a signal that they’re exercising caution, or they might be waiting for a last-minute surge. We’ll need to keep a close eye on any last-hour filings, but as it stands, the subscription numbers aren’t exactly setting the street on fire.

GMP Update

Now, let’s talk about the Grey Market Premium, or GMP. The current GMP for Jindal Supreme stands firm at ₹27. Interestingly, this is unchanged from yesterday’s ₹27. While a steady GMP is generally a positive sign, indicating a consistent demand in the unofficial market, the fact that it hasn’t climbed on the closing day is something to consider. A rising GMP often suggests growing investor confidence and a potential for a strong listing. The current ₹27 GMP, translating to an expected listing price of ₹120 (₹93 issue price + ₹27 GMP), still points towards a healthy listing gain. This ₹120 per share target is certainly attractive, offering a decent upside from the issue price. However, the lack of upward momentum in the GMP on this crucial day might reflect the same sentiment we’re seeing in the subscription numbers – a sense of cautious optimism rather than outright exuberance.

Should You Apply?

So, the big question: should you still be applying for Jindal Supreme shares? It’s a bit of a mixed bag, isn’t it? On one hand, you have the potential for a decent listing gain, as indicated by the GMP. The expected listing price of ₹120 offers a good return on your investment at the ₹93 issue price. The lot size of 161 shares means a modest investment per lot. However, the very low subscription numbers, especially on the closing day, are a genuine concern. This could signal a lack of broad-based investor interest or perhaps some hesitation due to market conditions or the company’s specific prospects. As always, it’s wise to remember the advice from SEBI registered investment advisors. They often suggest looking beyond just the GMP and considering the company’s fundamentals, future growth prospects, and your own risk appetite. If you’re looking for a quick listing gain and are comfortable with the current GMP, it might be a gamble worth taking. But if you’re a more conservative investor who prioritizes strong subscription figures and clear investor demand, you might want to exercise caution. It’s a judgment call, and you’ll need to weigh the potential upside against the current signals. For more in-depth analysis and all the nitty-gritty details, don’t forget to check out the full IPO details.

View Full Jindal Supreme (India) IPO Details